Apogee Announces Proposed Share Consolidation

Jun 14, 2015

Apogee Silver Ltd. announces a proposed consolidation of its common shares as approved by shareholders at its annual and special meeting held June 17, 2014 (the “Meeting”). At the Meeting shareholders approved a special resolution to amend the articles of incorporation of the Company to consolidate its issued and outstanding common shares (the “Common Shares”) on the basis of one (1) post-consolidated Common Share for up to a maximum of one hundred (100) pre-consolidated Common Shares, at the discretion of the Board for a period of one year following the Meeting. Upon review and approval of the Board of Directors, the Company proposes that it consolidates its Common Shares such that one (1) new post-consolidated Common Share would be issued for every sixty-five (65) Common Shares outstanding on the effective date of the consolidation, or such lower number as may be required to obtain approval of the TSX Venture Exchange.

Apogee currently has 450,816,059 Common Shares outstanding. Following the completion of the share consolidation on a sixty-five to one basis, Apogee would have approximately 6,935,631 Common Shares issued and outstanding. The change in the number of issued and outstanding common shares that would result from the share consolidation would not materially affect any shareholder’s percentage ownership in Apogee, although such ownership would be represented by a smaller number of common shares.

The proposed share consolidation is subject to the approvalof the TSX Venture Exchange.

About Apogee Silver Ltd.

Apogee Silver Ltd. is a mineral exploration and development stage company listed on the TSX Venture Exchange under the symbol APE. Apogee targets advanced, high grade silver-zinc-lead projects in South America. Currently its projects are located in the historic silver producing regions of northern Chile.

Cautionary Note Regarding Forward-Looking Information

This news release contains “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of 1995 and “forward-looking information” within the meaning of applicable Canadian securities legislation. Statements containing forward-looking information express, as at the date of this news release, the Transaction, the Company’s plans, estimates, forecasts, projections, expectations, or beliefs as to future events or results and the Company does not intend, and does not assume any obligation to, update such statements containing the forward-looking information. Such forward-looking statements and information include, but are not limited to statements as to: anticipated timing with respect to the implementation of the share consolidation, the effects of the share consolidation, the accuracy of estimated mineral reserves and resources, anticipated results of future exploration, and forecast future metal prices, and expectations that environmental, permitting, legal, title, taxation, socio-economic, political, marketing or other issues will not materially affect estimates of mineral reserves. These statements reflect the company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the Company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies.

These statements reflect the Company’s current views with respect to future events and are necessarily based upon a number of assumptions and estimates that, while considered reasonable by the company, are inherently subject to significant business, economic, competitive, political and social uncertainties and contingencies.
Many factors, both known and unknown, could cause actual results, performance or achievements to be materially different from the results, performance or achievements that are or may be expressed or implied by such forward-looking statements contained in this news release and the company has made assumptions and estimates based on or related to many of these factors. Such factors include, without limitation: statements with respect to the proposed share consolidation, risks related to the technological and operational nature of the company’s business; changes in national and local government, legislation, taxation, controls or regulations and political or economic developments in Canada and Chile, or other countries where the Company may carry on business in the future; risks and hazards associated with the business of mineral exploration, development and mining (including environmental hazards, industrial accidents, unusual or unexpected geological or structural formations, pressures, cave-ins and flooding); risks relating to the credit worthiness or financial condition of suppliers, refiners and other parties with whom the Company does business; inadequate insurance, or inability to obtain insurance, to cover these risks and hazards; employee relations; relationships with and claims by local communities and indigenous populations; availability and increasing costs associated with mining inputs and labour; the speculative nature of mineral exploration and development, including the risks of obtaining necessary licenses and permits and the presence of laws and regulations that may impose restrictions on mining; diminishing quantities or grades of mineral reserves as properties are mined; global financial conditions; business opportunities that may be presented to, or pursued by, the Company; the Company’s ability to complete and successfully integrate acquisitions and to mitigate other business combination risks; challenges to, or difficulty in maintaining, the Company’s title to properties and continued ownership thereof; the actual results of current exploration activities, conclusions of economic evaluations, and changes in project parameters to deal with unanticipated economic or other factors; increased competition in the mining industry for properties, equipment, qualified personnel, and their costs. Investors are cautioned against attributing undue certainty or reliance on forward-looking statements. Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated, described or intended. The Company does not intend, and does not assume any obligation, to update these forward-looking statements or information to reflect changes in assumptions or changes in circumstances or any other events affecting such statements or information, other than as required by applicable law.

Contact Information

Apogee Silver Ltd.
Jennifer Wagner
Interim Chief Executive Officer
+1 (416) 861-2269


biOasis Engages Kilmer Lucas for Cross-Border Investor Relations

Jun 14, 2015

BIOASIS TECHNOLOGIES INC. a pioneering biopharmaceutical company focused on overcoming the limitations of therapeutic drug delivery across the blood-brain barrier (BBB), announced today that it has retained Kilmer Lucas Inc. to provide it with Canadian and U.S. investor relations and strategic advisory services.

Kilmer Lucas combines a healthcare industry focus with a global reach. Working directly from its offices in Toronto, New York and San Francisco, and through a carefully assembled affiliate network that includes seasoned professionals based in Israel, Asia and Europe, Kilmer Lucas helps its clients to successfully navigate and penetrate the capital markets and media both at home and abroad. More information about the firm can be found at www.kilmerlucas.com.

“As biOasis continues to move aggressively forward into its commercialization phase, we are confident that Kilmer Lucas is the right partner to help us communicate our progress to a broader investor audience,” said Rob Hutchison, biOasis’ CEO.

Stephen Kilmer, President of Kilmer Lucas, commented, “We believe that a strong investment story is emerging at biOasis and we are excited that the company has chosen us to help tell it. Through the provision of a full range of investor relations and financial communications services, our primary goals will be to assist biOasis in achieving a fair and sustainable market valuation and to enhance the reputation that the company carries in the minds of investors, analysts and members of the media.”

Under the terms of the agreement, BiOasis will pay Kilmer Lucas a monthly retainer fee of C$6,500 for its services. Should BiOasis uplist its common shares for trading to a national U.S. stock exchange while this agreement is in effect, the monthly retainer fee paid by it to Kilmer Lucas will automatically increase to US$7,500. The agreement, which commences immediately, has an initial term of 60 days. Following the end of the initial term, the agreement will renew automatically for 30-day periods unless terminated by either party.

About biOasis

biOasis Technologies Inc. is a biopharmaceutical company headquartered in Vancouver, Canada focused on overcoming the limitations of therapeutic drug delivery across the BBB. The company is developing and commercializing a proprietary brain delivery technology to address unmet medical needs in the treatment of central nervous system disorders. biOasis trades on the OTCQX under the symbol “BIOAF” and on the TSX Venture Exchange under the symbol “BTI”. For more information about the company please visit www.bioasis.ca.

On Behalf of the Board of Directors

Rob Hutchison, Chairman & CEO

Contact Information

Company Contact:
biOasis Technologies Inc.
Mr. Rob Hutchison

Investor & Media Contact:
Kilmer Lucas Inc.
Stephen Kilmer


BioMmune Technologies Inc. Closes Non-Brokered Private Placement

Jun 13, 2015

BioMmune Technologies Inc. is pleased to announce that it has closed its non-brokered private placement announced on May 3rd, 2015. The Company has issued 5,000,000 units (each a “Unit”) at a price of CDN$0.20 per unit, for gross proceeds of CDN$1,000,000. Each Unit consists of one common share and one full common share purchase warrant. Each warrant entitles the holder to purchase one additional common share of the Company at a price of CDN$0.30 per share for a period of eighteen months up to and including December 8th, 2016,, subject to an exercise acceleration clause. Under the exercise acceleration clause, which the Company may exercise once the Units are free of resale restrictions and if the Company’s shares are trading at or above a volume weighted average price of $0.50 for 10 consecutive trading days, the Warrants will expire upon 30 days from the date the Company provides notice in writing to the Warrant holders via a news release. A cash finder’s fees of CDN$70,400 was paid on a portion of the financing. All securities issued are subject to a hold period of four (4) months and one day and as such may not be traded until October 9th, 2015. The net proceeds from the sale of units have been added to working capital in furtherance of the Company’s business.


BioMmune Technologies Inc. is a biopharmaceutical company headquartered in Vancouver, Canada. BioMmune is developing three technologies discovered at The University of British Columbia. They include, discovery of compounds that will be active in restoring immune-recognition of cancer cells resulting in the body’s immune system to fight the cancer cells. A discovery relating to Channels, whose activities regulate activity of cells involved in the immune system to improve their ability to combat cancers, infections and also autoimmunities. Furthermore, the company is pursuing the modulation of CD74, a protein involved in the immune system and its ability to fight foreign antigens. Finding ways or compounds that regulate its activity will improve the immune system to combat infections, cancers and autoimmune diseases. BioMmune trades on the TSX Venture Exchange under the symbol “IMU”.

On Behalf of the Board of Directors

Dr. Reinhard Gabathuler, President

Contact Information

BioMmune Technologies Inc.
Dr. Reinhard Gabathuler
1 (514) 963-6177


Vortex International Wins 2015 MVP Award From Aquatics International Magazine

Jun 12, 2015

Vortex Aquatic Structures International (www.vortex-intl.com), a manufacturer and world leader in aquatic play landscapes and entertainment solutions, is proud to announce that its Watermark product has won a 2015 MVP Award from Aquatics International Magazine. Voted by readers as one of the industry’s best new products, Watermark is an architectural installation that creates patterns and words by synchronizing lights and manipulating the flow of water.

Ideal for urban spaces, shopping centers, airports, exhibition centers, amusement parks, and hotels, Watermark uses valves and LED lighting to generate words, logos, and patterns. Easy to update via a secure app, Watermark can deliver pre-programmed sequences or tailored messaging for advertising, guest reception and promotion.

Available as a standalone unit or integrated into existing indoor and outdoor structures, Watermark uses minimal water and power, making it an efficient solution that can run consistently in high-traffic areas.

“We are honored that Watermark has been recognized by the knowledgeable readership of Aquatics International Magazine,” said Stephen Hamelin, president, Vortex International. “Watermark introduces a new dimension to the aquatics leisure experience and is a great way to grab the attention of customers and guests.”

Aquatic International’s Most Valuable Products are voted for by readers annually and include the 25 best new products of the year. Winners are featured in the magazine’s June MVP Awards issue.

See Watermark in action at http://bit.ly/vortex-watermark.

About Vortex

Vortex Aquatic Structures international, headquartered in Montreal, Canada, was founded in 1995 with the introduction of the first Splashpad®. Vortex’s use of the highest quality materials coupled with unique, inspiring design and state-of-the-art engineering, positioned the company as the world leader in aquatic play solutions.

In addition to its operations in Montreal, Vortex has regional sales and technical support offices in California, Michigan and Texas in the USA, Lyon and Paris in France, Valencia in Spain, Køge in Denmark and Shanghai and Beijing in China. The company has a global marketing and distribution network supporting Europe, Asia, the Middle East, Australia, and Latin America.

With over 6,000 installations worldwide, Vortex’s mission is to lead the aquatic play industry by continuing to develop the most fun, innovative and safe products for families and children of all ages and abilities.

For more information on Vortex Splashpad®, Poolplay™, Spraypoint™, Water Journey™ and Watermark solutions, please visit the company’s website at www.vortex-intl.com.

Contact Information

Media Contact:
Jason Broadhurst
Director of Marketing
(514) 694.3868 ext. 226


Cineplex Inc. to Present at the Gabelli & Company Movie & Entertainment Conference

Jun 10, 2015

Cineplex Inc. today announced that Gord Nelson, Chief Financial Officer, will present at the Gabelli & Company Movie & Entertainment conference on Thursday, June 11, 2015 at 11:30 a.m. ET. The conference is being held in New York City.

The conference will be webcast live and the audio presentation can be accessed via the Cineplex Inc. investor relations website at www.cineplex.com. The presentation will be archived for 30 days.

About Cineplex Inc.

Cineplex Inc. (“Cineplex”) is one of Canada’s leading entertainment companies and operates one of the most modern and fully digitized motion picture theatre circuits in the world. A top-tier Canadian brand, Cineplex operates numerous businesses including theatrical exhibition, food services, gaming, alternative programming (Front Row Centre Events), Cineplex Media, Cineplex Digital Solutions, Cineplex Digital Networks, and the online sale of home entertainment content through CineplexStore.com and on apps embedded in various electronic devices. Cineplex is also a joint venture partner in SCENE – Canada’s largest entertainment loyalty program.

Cineplex is headquartered in Toronto, Canada, and operates 162 theatres with 1,652 screens from coast to coast, serving approximately 74 million guests annually through the following theatre brands: Cineplex Odeon, SilverCity, Galaxy Cinemas, Scotiabank Theatres, Cineplex Cinemas and Cineplex VIP Cinemas. Cineplex also owns and operates the UltraAVX, Poptopia, and Outtakes brands. Cineplex trades on the Toronto Stock Exchange under the symbol CGX. More information is available at Cineplex.com.

Contact Information

Cineplex Inc.
Pat Marshall
Vice President Communications and Investor Relations


Nutritional High Announces Exclusive Partnership for Jimi Hendrix Products

Jun 10, 2015

Nutritional High International Inc. is pleased to announce that the Company has entered into an exclusive licensing agreement (“Agreement”), under which the Company may manufacture and distribute various marijuana and hemp-based edible products using the song titles and bearing the likeness of iconic guitarist Jimi Hendrix.

“Jimi Hendrix is one of the most legendary rock guitarists of all time and this partnership should create instant brand recognition for our edible marijuana products by Jimi’s fans across North America,” said David Posner, CEO of Nutritional High. “Entering into brand partnerships with the world’s foremost marijuana-related artists is a core component of our strategy, and we are honored to become part of Jimi’s legacy,” he added.

A variety of products under the “Edibles Experience” banner are in development including the “Purple Haze” line of THC-based products and the “Stone Free” line of CBD-based, non-psychoactive health products.

About the License

The License Agreement, entered into with Purple Haze Properties LLC (“PHP” or “Licensor”) on June 5, 2015, grants Nutritional High the exclusive right to manufacture and distribute marijuana and hemp oil-infused products including gummy bears, hard candies and health and energy drinkable products, and non-exclusive rights to manufacture and distribute certain apparel and accessories, in the United States and Canada. The term of the Agreement is for five years, with a renewal option for an additional five years.

Under the terms of the Agreement, Nutritional High will issue to the Licensor 3,333,334 common shares in the capital of the Company (the “Common Shares”) and shall pay additional annual fees and royalties of no less than $1,000,000 over five years, with such minimums payable in Common Shares or cash at the Company’s option.

In addition, Nutritional High announces that it has agreed to issue an aggregate of 700,000 Common Shares to new personnel who are joining the Company.

“We are pleased to be working with Nutritional High on Jimi’s entrance into the marijuana category. Nutritional High brings sophisticated manufacturing and marketing expertise and this will enable them to provide high quality products for Jimi’s fans everywhere. We look forward to building a leading presence in this rapidly-growing category, both as licensors and as shareholders,” said Andrew Pitsicalis, CEO of Purple Haze Properties.

About Nutritional High International Inc.

Nutritional High is primarily focused on developing, acquiring and designing products and brands in the marijuana-infused edible products and oil extracts sectors for medical and adult recreational use. The Company works exclusively in U.S. states where such activity is permitted and regulated by state law, through entities which hold a valid license to produce marijuana-infused edible products and to distribute, and dispense marijuana products.

This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Such statements include submission of the relevant documentation within the required timeframe and to the satisfaction of the relevant regulators, completing the acquisition of the applicable real estate and raising sufficient financing to complete the Company’s business strategy. There is no certainty that any of these events will occur. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.

Company’s securities offered have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act”), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.

Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Contact Information

Nutritional High International Inc.
David Posner
(647) 985-6727

Hudes Communications International
Nelson Hudes
(416) 271-5557


Lumenpulse Appoints Marc Filion to Executive Team

Jun 9, 2015

Lumenpulse is proud to announce the appointment of Marc Filion to the executive team. Mr. Filion, a 25-year veteran of the technology industry, will take on the role of Chief Commercial Officer, overseeing global sales and marketing. His appointment bolsters an already dynamic and versatile executive team for Lumenpulse, which now has six offices and more than 410 employees worldwide.

“Marc’s appointment is another step forward to accelerate our strategic growth plan,” said François-Xavier Souvay, President and CEO of Lumenpulse. “He is a proven business leader, with a stellar track record in strategic planning, delivering revenue growth, and helping to define and develop product roadmaps. His experience and knowledge is an invaluable addition to our team, and it will only solidify our focus moving forward,” he said.

Mr. Filion brings considerable experience from the technology industry. He contributed to the creation of one of Canada’s most successful ecommerce and internet solution company, Emergis, where he held numerous executive positions. Following the acquisition of Emergis by TELUS, Mr. Filion served as Chief Operating Officer of TELUS Health and Financial Solutions, Canada’s leading internet solution provider with 1600 employees across the country.

“I am proud to be joining Lumenpulse,” Mr. Filion said. “The company has rapidly built a world-class brand, with an expanding product portfolio that continues to push the boundaries of LED lighting and technology. I’m very excited to be a part of Lumenpulse’s growth and success,” he said.

For more information, please visit Lumenpulse.com.

Editor’s Notes:

About Lumenpulse Inc.

Founded in 2006, Lumenpulse designs, develops, manufactures and sells a wide range of high performance and sustainable specification-grade LED lighting solutions for commercial, institutional and urban environments. Lumenpulse is a leading pure-play specification-grade LED lighting solutions provider and has earned many awards and recognitions, including several Product Innovation Awards (PIA), three Next Generation Luminaires Design Awards, a Red Dot Product Design Award and a Lightfair Innovation Award. Lumenpulse has more than 410 employees worldwide, with corporate headquarters in Montreal, Canada, and offices in Québec City, Boston, Paris, London and Manchester. Lumenpulse is listed on the Toronto Stock Exchange under the symbol LMP.

Contact Information

Salvatore Ciolfi
Public Relations Manager
1 (514) 937-3003 ext. 337


WPCS Signs Definitive Agreement to Sell Its Interest in China Operations

Jun 9, 2015

WPCS International Incorporated , which specializes in contracting services for communications infrastructure domestically and natural gas and petroleum transmission pipelines internationally, announced today that on June 3, 2015 it entered into an interest purchase agreement to sell its 60% joint venture and profit interest in Tai’an AGS Pipeline Construction Co. Ltd., a contractual joint venture established in accordance with the laws of the People’s Republic of China (“TAGS”), to Canada-based Halcyon Coast Investment (Canada) Ltd., in an “as-is”, all-cash transaction for a total purchase price of $1,500,000, which includes a $150,000 refundable deposit that was paid at signing. The closing of this transaction is subject to the approval of the Tai’an Bureau of Commerce and Industry.

According to Interim CEO Sebastian Giordano, “While we value the long-standing relationship with our joint venture partner, selling TAGS has been an important component of our operational restructuring plan, which has resulted in the closure of the Trenton Operations and the divestitures of both the Seattle and Australia Operations. The proceeds of this sale will provide working capital to the Company.”

About WPCS International Incorporated
WPCS provides contracting services to the public services, healthcare, energy and corporate enterprise markets in the United States and China. For more information, please visit www.wpcs.com.

Contact Information

WPCS International Incorporated
David Allen
Chief Financial Officer
Phone: 707.759.6008


ArjoHuntleigh and BAM Labs Deliver Smart Bed Technology to Healthcare Market

Jun 8, 2015

ArjoHuntleigh, Inc., the leader in pressure ulcer prevention and patient safety, and BAM Labs, the pioneer of smarter health monitoring, today announced a U.S. distribution partnership to provide BAM Labs Smart Bed Technology to the acute and postacute markets. BAM Labs Smart Bed Technology is designed to turn any bed into a platform to improve care quality, increase team efficiency and reduce costs. Healthcare facilities and communities can immediately contact ArjoHuntleigh to purchase BAM Labs’ Smart Bed solution and receive customer support, training, and clinical support.

BAM Labs’ Smart Bed Technology is proven to reduce pressure sores by 85.4%1. In a formal study, residents at 3 long-term care centers were evaluated for risk of developing a pressure ulcer based on their Braden Scale for Predicting Pressure Sore Risk. A peer-reviewed journal validated the results and verified that BAM Labs’ Smart Bed Technology optimizes repositioning and supports the latest healthcare quality mandates.

“BAM Labs Smart Bed solution is an exciting addition to our portfolio of products and programs aimed at Preventing the Preventables such as Pressure Ulcers and Patient Falls, which are an often avoidable drain on healthcare resources and negatively impact patient care,” said ArjoHuntleigh President Paul Chapman.

“We believe that data-driven care provides for the best possible management of individual needs,” said Rich Rifredi, CEO, BAM Labs. “We expect to see BAM Labs Smart Bed Technology used to assess dozens of health indicators in the future as demand for more intelligent information grows.”

“Our partnership with ArjoHuntleigh expands our ability to provide Smart Bed Technology globally,” said Mike Hanson, VP Strategic Partnerships, BAM Labs. “We look forward to working closely with their international team, as they are ideally positioned to put BAM Labs Smart Bed Technology into play to provide patient-centered care, reduce cost, and increase care team efficiency.”

How BAM Labs Smart Bed Technology Works
The FDA-registered BAM Labs Smart Bed Technology sensor mat is placed under any mattress and continuously detects patient motion and presence. Biometric data is automatically transmitted to the BAM Labs Smart Bed cloud platform where it is analyzed and returned to caregivers, packaged in powerful, user-friendly applications viewable on any internet-connected device.

About ArjoHuntleigh Inc.
ArjoHuntleigh Inc. is a member of the Getinge AB Group, a leading global provider of equipment and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. Equipment, service and technologies are supplied under the brands ArjoHuntleigh Inc. for patient handling and hygiene, disinfection, DVT prevention, medical beds, therapeutic surfaces and diagnostics, GETINGE for infection control and prevention within healthcare and life science and MAQUET for surgical work places, cardiopulmonary and critical care. ArjoHuntleigh USA offers a broad range of integrated solutions for the care of people with reduced mobility and related conditions, with the aim to enhance the quality of care in elderly care facilities, hospitals and other healthcare environments.

About BAM Labs
BAM Labs® is the leading innovator in Smart Bed Technology®. In the medical market, BAM Labs’ FDA-registered Touch-free Life Care™ smart bed sensor and cloud monitoring platform transforms any bed into a smart bed to inform, manage and improve health. BAM Labs’ Smarter Health Monitoring captures strategic insights into life-long health and wellness, all while you sleep. Unlike watches and small gadgets that you have to power-up daily and remember to put on or carry with you, BAM Labs Smart Bed Technology turns any bed into a smart device that you can set and forget. The BAM Labs Smart Bed Technology solution is available through authorized distribution partners in the United States and Canada. BAM Labs’ Smart Bed Technology solutions are also being used to create breakthrough consumer products, notably the SleepIQ™ technology only available with a Sleep Number® bed at one of the 450 Sleep Number stores across the country. Visit http://www.bamlabs.com or contact info@bamlabs.com.

1 (Beaty, Jeff A. and Sauer, Timothy M. “The Efficacy of Goodmark Medical’s Solution Using the BAM Labs’® Smart Bed Technology® in the Prevention of Pressure Ulcers.” Journal of Aging Science 2 (2014): 123)

Contact Information

Editorial Contacts:

BAM Labs
Heidi Groshelle
Groshelle Communications
Tel +1 415.307.1380


Lonestar West Inc. Announces Executive Change at the VP Finance and CFO Position

Jun 2, 2015

Lonestar West Inc. is pleased to announce that Mark Kearl, CA has joined Lonestar as its Vice President, Finance and Chief Financial Officer. Effective immediately, Kristina Scade, the current Chief Financial Officer, will transition to a new position, Vice President, Internal Reporting.

Mr. Kearl brings extensive financial and operational experience in the energy services industry in both the Canadian and international marketplace. Most recently, Mr. Kearl spent eight years as Vice President, Finance and Chief Financial Officer of Total Energy Services Inc., a Toronto Stock Exchange listed diversified energy services company. Prior to joining the energy services industry in 2005, Mr. Kearl spent five years at a national financial advisory services firm and four years with a national accounting and advisory services firm. Mr. Kearl received his Bachelor of Commerce degree from the University of Calgary in 1997 and his Chartered Accountant designation in 2000.

“We are pleased to add Mark to our management team as we focus on building out our business platform. We believe that Mark’s direct industry experience will be invaluable as we continue to grow our business,” commented James Horvath, President of Lonestar. “We are also pleased that Kristina Scade will continue to be part of our management team as her contributions have been important during our high-growth period.”

About Lonestar West

Based in Sylvan Lake, Alberta, Lonestar West Inc. operates a fleet of 153 Hydrovac, Vacuum and Auxiliary units throughout Western Canada, Ontario, California, and the Southern United States. It is focused on profitably growing its HVAC services to become a major competitor in the North American market.

For more information please visit the Lonestar West website at www.lonestarwest.com.

Contact Information